BioCentury
ARTICLE | Finance

Eyes on launches

Why buysiders are eyeing sales rather than clinical data in 3Q18

June 30, 2018 3:04 AM UTC

The annual summer slowdown isn’t restricted to just the stock market this year, as the clinical catalyst calendar also appears to be on holiday in 3Q18.

Buysiders are therefore turning their attention to a spate of ongoing or upcoming product launches, with a keen focus on new modalities such as CAR T and gene therapies...